PerkinElmer, Inc. Agrees to Sell Illumination and Detection Solutions Business to Veritas Capital for Approximately $500 Million
Now they have the money to buy Genzyme Genetics
PerkinElmer, Inc. Agrees to Sell Illumination and Detection Solutions Business to Veritas Capital for Approximately $500 Million
Now they have the money to buy Genzyme Genetics
Desperation? Pre IPO shakedown? They have $3.7M left, how long before the lawyers chew through that?
We expect to see an increase in licensing deals and acquisitions as the big pharma players need to increase their pipelines," says Jim Prutow, director at management consulting firm PRTM.
by Morningstar Credit Committee | 08-19-10 | 4:24AM
WAYNE, PA, Aug 05, 2010 (MARKETWIRE via COMTEX) -- Kenexa, a global provider of business solutions for human resources, today announced that Bob Hurley, Chairman of Beckman Coulter Japan and Senior Vice President, Human Resources of Beckman Coulter, will join best-selling author Malcolm Gladwell and other notable presenters as a keynote speaker at the upcoming 2010 Kenexa World Conference.
Beckman Coulter today announced a record contract with CML HealthCare ("CML") of Toronto, Canada. According to the company, the deal represents the largest contract of any Canadian diagnostics company for a single testing site.
Illumina bought Helixis for ~$100 million.
If they sell a qPCR instrument now, what's next? qPCR kits?
Was this a good acquisition by Illumina? Is Illumina the new borg, buying up technology instead of creating new products on their own? Thoughts?
ORANGE COUNTY, Calif., July 22, 2010 /PRNewswire via COMTEX/ -- Beckman Coulter, Inc. (BEC 53.00, -6.90, -11.52%) , a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today second quarter and first half ended June 30, 2010 results.
EU Clears Merck KGaA (EMD in USA and Canada)To Buy Millipore
The European Commission Wednesday cleared German pharmaceutical and chemical company Merck KGaA (MRK.XE) to buy U.S. laboratory and biotech supply company Millipore (MIL) for $7.2 billion, including debt.
Does anyone know which firm Sanofi-Aventis are looking at in the US?